Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100. Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A shorter period RSI is more reactive to recent price changes, so it can show early signs of reversals. 9-Day RSI is sometimes used together with 14-Day RSI in a two period divergence strategy.
SHSE:688767's 9-Day RSI is ranked worse than 65.42% of 1420
companies
in the Biotechnology industry
Industry Median: 40.575
vs SHSE:688767: 51.03
Hangzhou Biotest Biotech Co (SHSE:688767) 9-Day RSI Explanation
The Relative Strength Index (RSI), developed by J. Welles Wilder in his book “New Concepts in Technical Trading Systems.”, is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100.
Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A RSI surpasses the 30 level indicates a bullish sign, when it slides below 70 level, it’s a bearish sign. This level can be adjusted depending on the security’s pattern and the market’s underlying trend. In an uptrend or bullish market, the RSI might range within a higher interval, investors could set the support level higher. If a downtrend or bearish market occurs, investors may need to lower the resistance level.
RSI can also be used in trading techniques to indicate the trading signal, such as Divergences and Swing Rejections. A shorter period RSI is more reactive to recent price changes, so it can show early signs of reversals. 9-Day RSI is sometimes used together with 14-Day RSI in a two period divergence strategy.
Hangzhou Biotest Biotech Co 9-Day RSI Related Terms
SHSE:688767 vs VRTX, REGN, RVMD: 9-Day RSI Comparison
For the Biotechnology subindustry, Hangzhou Biotest Biotech Co's 9-Day RSI, along with its competitors' market caps and 9-Day RSI data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Hangzhou Biotest Biotech Co 9-Day RSI vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Hangzhou Biotest Biotech Co's 9-Day RSI distribution charts can be found below:
* The bar in red indicates where Hangzhou Biotest Biotech Co's 9-Day RSI falls into.
Hangzhou Biotest Biotech Co (SHSE:688767) 9-Day RSI Calculation
The formula for calculating RSI is:
RSI
=
100
–
[ 100
/
( 1 + Average Gain
/
Average Loss )]
* Note that the formula uses a positive value for the average loss.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Hangzhou Biotest Biotech Co (SHSE:688767) has a 9-Day RSI of 51.03 as of Jul. 30, 2026. According to the industry distribution chart, Hangzhou Biotest Biotech Co ranks #929 out of 1420 companies in the Biotechnology industry, placing it in the top 65.4%.
Is Hangzhou Biotest Biotech Co's 9-Day RSI too high?
Hangzhou Biotest Biotech Co's current 9-Day RSI is 51.03. The Biotechnology industry median 9-Day RSI is 40.58. Hangzhou Biotest Biotech Co's value of 51.03 is 25.8% above this industry median. Based on the distribution chart, Hangzhou Biotest Biotech Co ranks #929 out of 1420 companies in the Biotechnology industry, which is below the industry midpoint. Overall, Hangzhou Biotest Biotech Co has a GF Score™ of 68/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Hangzhou Biotest Biotech Co's 9-Day RSI compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Hangzhou Biotest Biotech Co ranks #929 out of 1420 companies for 9-Day RSI. This places Hangzhou Biotest Biotech Co in the lower half of its industry. The industry median 9-Day RSI is 40.58. Hangzhou Biotest Biotech Co's value of 51.03 is 25.8% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 9-Day RSI for a Biotechnology company?
The median 9-Day RSI among Biotechnology companies is 40.58, based on 1,420 companies in the industry. Companies in the top quartile (top 25%) have a 9-Day RSI significantly above this median, while those in the bottom quartile fall well below. However, 9-Day RSI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Hangzhou Biotest Biotech Co's current 9-Day RSI of 51.03 is 25.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 9-Day RSI mean?
A high 9-Day RSI can signal that a stock is expensive relative to its fundamentals. For the Biotechnology industry, the median 9-Day RSI is 40.58 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Hangzhou Biotest Biotech Co's current 9-Day RSI is 51.03. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hangzhou Biotest Biotech Co stock overvalued right now?
Based on GuruFocus' analysis, Hangzhou Biotest Biotech Co (SHSE:688767) is currently considered Significantly Overvalued. The stock's GF Value™ is ¥27.32, compared to a current price of ¥35.78 — trading 31% above its estimated fair value. The current 9-Day RSI is 51.03 and 25.8% above the Biotechnology industry median of 40.58. Hangzhou Biotest Biotech Co's overall GF Score™ is 68/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 9-Day RSI calculated?
9-Day RSI is calculated from a company's financial statements. For Hangzhou Biotest Biotech Co (SHSE:688767), the current 9-Day RSI is 51.03 as of Jul. 30, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Hangzhou Biotest Biotech Co (SHSE:688767) Overvalued in 2026?
Based on GuruFocus' analysis, Hangzhou Biotest Biotech Co stock appears to be overvalued.
The current stock price of ¥35.78 is trading 31% above its estimated GF Value™ of ¥27.32.
GuruFocus considers Hangzhou Biotest Biotech Co to be Significantly Overvalued.
Key valuation signals for SHSE:688767:
9-Day RSI: 51.03
GF Value™: ¥27.32 vs. price of ¥35.78 (31% above fair value)
Industry Position: 25.8% above the Biotechnology median (#929 of 1420)
No single metric tells the full story. See the SHSE:688767 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Hangzhou Biotest Biotech Co Ltd is engaged in the research and development, manufacturing, sales and service of in vitro diagnostic reagents, raw materials and instruments.
68GF Score
Get the complete analysis for SHSE:688767
9-Day RSI is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:688767 has been successfully added to your 
